<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Cardiovasc Ultrasound</journal-id>
      <journal-title>Cardiovascular Ultrasound</journal-title>
      <issn pub-type="epub">1476-7120</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">15857518</article-id>
      <article-id pub-id-type="pmc">1097744</article-id>
      <article-id pub-id-type="publisher-id">1476-7120-3-11</article-id>
      <article-id pub-id-type="doi">10.1186/1476-7120-3-11</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Reduced coronary flow reserve in Anderson-Fabry disease measured by transthoracic Doppler echocardiography</article-title>
      </title-group>
      <contrib-group>
        <contrib id="A1" corresp="yes" contrib-type="author">
          <name>
            <surname>Dimitrow</surname>
            <given-names>Pawe&#x142; Petkow</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>dimitrow@mp.pl</email>
        </contrib>
        <contrib id="A2" contrib-type="author">
          <name>
            <surname>Krzanowski</surname>
            <given-names>Marek</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>mmkrzano@cyf-kr.edu.pl</email>
        </contrib>
        <contrib id="A3" contrib-type="author">
          <name>
            <surname>Undas</surname>
            <given-names>Anetta</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>mmundas@cyf-kr.edu.pl</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>2nd Department of Cardiology, Collegium Medicum Jagiellonian University, Cracow, Poland</aff>
      <aff id="I2"><label>2</label>2nd Department of Internal Medicine, Collegium Medicum Jagiellonian University, Cracow, Poland</aff>
      <pub-date pub-type="collection">
        <year>2005</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>27</day>
        <month>4</month>
        <year>2005</year>
      </pub-date>
      <volume>3</volume>
      <fpage>11</fpage>
      <lpage>11</lpage>
      <ext-link ext-link-type="uri" xlink:href="http://www.cardiovascularultrasound.com/content/3/1/11"/>
      <history>
        <date date-type="received">
          <day>13</day>
          <month>4</month>
          <year>2005</year>
        </date>
        <date date-type="accepted">
          <day>27</day>
          <month>4</month>
          <year>2005</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2005 Dimitrow et al; licensee BioMed Central Ltd.</copyright-statement>
        <copyright-year>2005</copyright-year>
        <copyright-holder>Dimitrow et al; licensee BioMed Central Ltd.</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0">
          <p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p>
          <!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author>
               Dimitrow
               Petkow
               Pawe&#x00142;
               
               dimitrow@mp.pl
            </dc:author><dc:title>
            Reduced coronary flow reserve in Anderson-Fabry disease measured by transthoracic Doppler echocardiography
         </dc:title><dc:date>2005</dc:date><dcterms:bibliographicCitation>Cardiovascular Ultrasound 3(1): 11-. (2005)</dcterms:bibliographicCitation><dc:identifier type="sici">1476-7120(2005)3:1&#x0003c;11&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1476-7120</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>-->
        </license>
      </permissions>
      <abstract>
        <p>Coronary flow reserve was assessed in a patient with Anderson-Fabry disease complicated by symmetric left ventricular hypertrophy. Coronary flow reserve was measurable in all three major coronary arteries providing an opportunity to compare regional coronary flow reserve from different vascular beds. In this patient all the three vascular beds supplied diffusely hypertrophied myocardium. Coronary flow disturbances in small intramyocardial perforating arteries were visible. The coronary flow reserve was reduced to a similar level (around to 2.0) in all three major arteries. In our patient with Anderson-Fabry disease, the coronary vasodilatation was blunted in a diffuse pattern corresponding to the myocardial hypertrophy distribution. In small intramyocardial arteries coronary flow was also disturbed. Accordingly, retrograde systolic flow and accelerated anterograde diastolic flow were documented.</p>
      </abstract>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Background</title>
      <p>Anderson-Fabry disease is an X-linked, multisystem, lysosomal storage disease (deficiency of enzyme &#x3B1;-galactosidase A), characterized by the accumulation of glycosphingolipids in various tissues and organs [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>], including skin, vascular endothelium, heart, kidneys, liver, lungs, pancreas and ganglion cells of the peripheral nervous system. The incidence is 1:117000. However, the rate may be underestimated because a common cardiac manifestation is myocardial hypertrophy that mimics hypertrophic cardiomyopathy. Abnormal storage in the cardiovascular system may also involve cardiac conduction system, valvular apparatus and endothelial cells in coronary vessels [<xref ref-type="bibr" rid="B1">1</xref>-<xref ref-type="bibr" rid="B3">3</xref>].</p>
      <p>To assess coronary flow abnormalities in a patient with Anderson-Fabry disease, we performed transthoracic Doppler echocardiography. Using this method, coronary flow reserve is effectively measurable [<xref ref-type="bibr" rid="B4">4</xref>] and all three major coronary arteries are accessible in some patients [<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B6">6</xref>]. In a large series of 658 patients [<xref ref-type="bibr" rid="B6">6</xref>], coronary flow reserve was contemporarily recorded in left anterior descending (LAD) coronary artery (98% of patients), right coronary artery (RCA) (66% of patients) and circumflex (Cx) coronary artery (43% of patients). Additionally, flow disturbances in small intramyocardial perforating arteries were assessed as blood flow abnormalities at this level of coronary circulation were previously reported in left ventricular (LV) hypertrophy [<xref ref-type="bibr" rid="B7">7</xref>].</p>
    </sec>
    <sec>
      <title>Case presentation</title>
      <p>This 49-year-old male patient with Anderson-Fabry disease was referred to our hospital. He did not complain of anginal symptoms or dyspnea. As a part of an overall clinical evaluation, transthoracic echocardiography was performed, revealing a diffusely distributed myocardial hypertrophy, i.e. involving both (LV) free walls and the septum (the myocardial thickness at diastole was measured in the short parasternal-axis: the anterior segment of the septum- 19.6 mm; the posterior segment of the septum &#x2013; 20.8 mm; the LV posterior wall &#x2013; 20.7 mm; and the anterolateral wall 16.8 mm). Left ventricular systolic function was preserved (LV ejection fraction 68%). A precise assessment of myocardial hypertrophy by magnetic resonance imaging confirmed increased LV mass to 386 grams.</p>
    </sec>
    <sec sec-type="methods">
      <title>Methods</title>
      <p>Using noninvasive, inexpensive and widely accessible method, B-mode and color Doppler transthoracic echocardiography, the segments of three major coronary arteries: LAD, Cx and right posterior descending (RPD) coronary artery or RCA were visualized (Figure <xref ref-type="fig" rid="F1">1</xref>,<xref ref-type="fig" rid="F2">2</xref>). High quality recordings of flow velocity in all these coronary arteries were obtained using spectral Doppler.</p>
      <fig position="float" id="F1">
        <label>Figure 1</label>
        <caption>
          <p>Parasternal short axis view, color Doppler examination at the heart base level. Left main, left anterior descending (LAD) and origin of left circumflex (Cx) coronary arteries are seen. Blood flow within the left main coronary artery and proximal LAD is depicted in red, while in the Cx &#x2013; in blue.</p>
        </caption>
        <graphic xlink:href="1476-7120-3-11-1"/>
      </fig>
      <fig position="float" id="F2">
        <label>Figure 2</label>
        <caption>
          <p>Modified apical four-chamber view, color Doppler examination. Flow detected in long segment of the right posterior descending (RPD) coronary artery is depicted in red.</p>
        </caption>
        <graphic xlink:href="1476-7120-3-11-2"/>
      </fig>
    </sec>
    <sec>
      <title>Results</title>
      <p>The coronary flow reserve in response to intravenous adenosine (140 &#x3BC;g/kg/min) was homogeneously reduced to a similar value in the major coronary arteries (LAD &#x2013; 2.07; Cx- 2.18; RPD/RCA- 1.91). Small, intramyocardial branches of epicardial coronary arteries were visualized [intramyocardial perforators originated from LAD (Figure <xref ref-type="fig" rid="F3">3</xref>) and branches from RPD (Figure <xref ref-type="fig" rid="F4">4</xref>)]. Increased resistance to flow (probably due to myocardial hypertrophy and increased extravascular compressive forces) was demonstrated by the detection of flow with high velocity in spectral Doppler (figure <xref ref-type="fig" rid="F5">5</xref>, <xref ref-type="fig" rid="F6">6</xref>, <xref ref-type="fig" rid="F7">7</xref>) and color Doppler (Figures <xref ref-type="fig" rid="F3">3</xref>, <xref ref-type="fig" rid="F4">4</xref>, <xref ref-type="fig" rid="F5">5</xref>) in these penetrating vessels. The peak diastolic flow velocity was higher in the LAD perforator (41 cm/s &#x2013; figure <xref ref-type="fig" rid="F6">6</xref>) than in the distal portion of LAD (25 cm/s &#x2013; figure <xref ref-type="fig" rid="F7">7</xref>). The systolic flow in the LAD perforator was abnormally retrograde (figure <xref ref-type="fig" rid="F6">6</xref>).</p>
      <fig position="float" id="F3">
        <label>Figure 3</label>
        <caption>
          <p>Modified apical 2-chamber view, apical area, color Doppler examination. The LAD and the penetrating intramyocardial arteries (vertical perforators branching of the LAD) are seen.</p>
        </caption>
        <graphic xlink:href="1476-7120-3-11-3"/>
      </fig>
      <fig position="float" id="F4">
        <label>Figure 4</label>
        <caption>
          <p>Modified apical 2-chamber view, middle segment of the inferior wall on color Doppler examination. Small (arch-shaped) arteries branching of the right posterior descending (RPD) coronary artery are seen.</p>
        </caption>
        <graphic xlink:href="1476-7120-3-11-4"/>
      </fig>
      <fig position="float" id="F5">
        <label>Figure 5</label>
        <caption>
          <p>The orientation of Doppler gate within the LAD perforator.</p>
        </caption>
        <graphic xlink:href="1476-7120-3-11-5"/>
      </fig>
      <fig position="float" id="F6">
        <label>Figure 6</label>
        <caption>
          <p>The flow velocity spectrum in the LAD perforator visualized in figure 5. In diastole the flow velocity is negative (towards ventricular chamber) and during systole the retrograde flow (towards epicardium) results in positive value of velocity.</p>
        </caption>
        <graphic xlink:href="1476-7120-3-11-6"/>
      </fig>
      <fig position="float" id="F7">
        <label>Figure 7</label>
        <caption>
          <p>Diastolic flow velocity spectrum in distal portion of LAD.</p>
        </caption>
        <graphic xlink:href="1476-7120-3-11-7"/>
      </fig>
    </sec>
    <sec>
      <title>Discussion</title>
      <p>Prevalence of Anderson-Fabry disease in patients with late-onset hypertrophic cardiomyopathy is about 6.3% in males [<xref ref-type="bibr" rid="B8">8</xref>] and 12% in females [<xref ref-type="bibr" rid="B9">9</xref>]. In contrast, among males with hypertrophic cardiomyopathy diagnosed at &lt;40 years of age, the rate of appropriate verification of the diagnosis to Anderson-Fabry disease was lower i.e. 1.4% [<xref ref-type="bibr" rid="B8">8</xref>]. If properly recognized, Anderson-Fabry disease is treatable by enzyme replacement therapy and both cardiac and non-cardiac abnormalities may be reversed/reduced by substitution of &#x3B1;-galactosidase (especially in the early stage) [<xref ref-type="bibr" rid="B10">10</xref>]. Therefore, it is important to consider Anderson-Fabry disease in the differential diagnosis of hypertrophic cardiomyopathy. Anderson-Fabry disease is hardly indistinguishable from hypertrophic cardiomyopathy by echocardiography [<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B12">12</xref>], however we made an attempt to identify potential differences (mainly quantitative) in table <xref ref-type="table" rid="T1">1</xref>. Recently [<xref ref-type="bibr" rid="B13">13</xref>], the findings of magnetic resonance imaging have appeared useful in differential diagnosis (table <xref ref-type="table" rid="T1">1</xref>). Clinical findings may be more helpful in differential diagnosis and we recommend to evaluate the presence or absence of all non-cardiac manifestations (dermatological, nephrological, neurological, ophthamological) of Anderson-Fabry disease in patients diagnosed as having hypertrophic cardiomyopathy.</p>
      <table-wrap position="float" id="T1">
        <label>Table 1</label>
        <caption>
          <p>Comparison of echocardiography and MRI findings between Anderson-Fabry and hypertrophic cardiomyopathy.</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <td align="center" colspan="3">Echocardiography</td>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td/>
              <td align="left">Anderson-Fabry</td>
              <td align="left">HCM</td>
            </tr>
            <tr>
              <td colspan="3">
                <hr/>
              </td>
            </tr>
            <tr>
              <td align="left">LVH pattern</td>
              <td align="left">Concentric&gt;Asymmetric</td>
              <td align="left">Asymmetric&gt;Concentric</td>
            </tr>
            <tr>
              <td colspan="3">
                <hr/>
              </td>
            </tr>
            <tr>
              <td align="left">Resting LVOT gradient</td>
              <td align="left">Rare</td>
              <td align="left">25&#x2013;30%</td>
            </tr>
            <tr>
              <td colspan="3">
                <hr/>
              </td>
            </tr>
            <tr>
              <td align="left">Massive LVH&gt; 30 mm</td>
              <td align="left">Rare</td>
              <td align="left">10&#x2013;15%</td>
            </tr>
            <tr>
              <td colspan="3">
                <hr/>
              </td>
            </tr>
            <tr>
              <td align="left">LV diastolic dysfunction (tissue Doppler, strain rate)</td>
              <td/>
              <td/>
            </tr>
            <tr>
              <td align="left">&#x2003;&#x2003;With LVH</td>
              <td align="left">Yes</td>
              <td align="left">Yes</td>
            </tr>
            <tr>
              <td align="left">&#x2003;&#x2003;Without LVH (genotype +)</td>
              <td align="left">Yes</td>
              <td align="left">Yes</td>
            </tr>
            <tr>
              <td colspan="3">
                <hr/>
              </td>
            </tr>
            <tr>
              <td align="left">LV systolic dysfunction</td>
              <td align="left">More frequent especially in older males</td>
              <td/>
            </tr>
            <tr>
              <td colspan="3">
                <hr/>
              </td>
            </tr>
            <tr>
              <td align="center" colspan="3">Magnetic resonance</td>
            </tr>
            <tr>
              <td colspan="3">
                <hr/>
              </td>
            </tr>
            <tr>
              <td align="left">Most common site of late-enhancement (if present)</td>
              <td align="left">Infero-lateral segment</td>
              <td align="left">Ventricular junction, Multi-focal</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <p>LVH- left ventricular hypertrophy; LVOT &#x2013; left ventricular outflow tract</p>
        </table-wrap-foot>
      </table-wrap>
    </sec>
    <sec>
      <title>Conclusion</title>
      <p>In our patient with Anderson-Fabry disease, the coronary vasodilatation was blunted in a diffuse pattern corresponding to the myocardial hypertrophy distribution. In small intramyocardial arteries coronary flow was disturbed. Accordingly, retrograde systolic flow and accelerated anterograde diastolic flow were documented. Transthoracic Doppler echocardiography is now the only method available to evaluate blood flow characteristics in small intramyocardial arteries.</p>
    </sec>
    <sec>
      <title>List of Abbreviations</title>
      <p>LAD &#x2013; left anterior descending coronary artery</p>
      <p>RCA &#x2013; right coronary artery</p>
      <p>RPD &#x2013; right posterior descending coronary artery</p>
      <p>Cx &#x2013; circumflex coronary artery</p>
    </sec>
    <sec>
      <title>Competing Interests</title>
      <p>The author(s) declare that they have no competing interests.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Linhart</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Palecek</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Bultas</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Ferguson</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Hrudova</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Karetova</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Zeman</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Ledvinova</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Poupetova</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Elleder</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Aschermann</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>New insights in cardiac structural changes in patients with Fabry's disease</article-title>
          <source>Am Heart J</source>
          <year>2000</year>
          <volume>139</volume>
          <fpage>1101</fpage>
          <lpage>1108</lpage>
          <pub-id pub-id-type="pmid">10827394</pub-id>
          <pub-id pub-id-type="doi">10.1067/mhj.2000.105105</pub-id>
        </citation>
      </ref>
      <ref id="B2">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kampmann</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Wiethoff</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Perrot</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Beck</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Dietz</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Osterziel</surname>
              <given-names>KJ</given-names>
            </name>
          </person-group>
          <article-title>The heart in Anderson Fabry disease</article-title>
          <source>Z Kardiol</source>
          <year>2002</year>
          <volume>91</volume>
          <fpage>786</fpage>
          <lpage>795</lpage>
          <pub-id pub-id-type="pmid">12395219</pub-id>
          <pub-id pub-id-type="doi">10.1007/s00392-002-0848-5</pub-id>
        </citation>
      </ref>
      <ref id="B3">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Doi</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Toda</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Yano</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Sisters with atypical Fabry's disease with complete atrioventricular block</article-title>
          <source>Heart</source>
          <year>2003</year>
          <volume>89</volume>
          <fpage>e2</fpage>
          <pub-id pub-id-type="pmid">12482812</pub-id>
          <pub-id pub-id-type="doi">10.1136/heart.89.1.e2</pub-id>
        </citation>
      </ref>
      <ref id="B4">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dimitrow</surname>
              <given-names>PP</given-names>
            </name>
          </person-group>
          <article-title>Transthoracic Doppler echocardiography- noninvasive diagnostic window for coronary flow reserve assessment</article-title>
          <source>Cardiovasc Ultrasound</source>
          <year>2003</year>
          <volume>1</volume>
          <fpage>4</fpage>
          <pub-id pub-id-type="pmid">12740038</pub-id>
          <pub-id pub-id-type="doi">10.1186/1476-7120-1-4</pub-id>
        </citation>
      </ref>
      <ref id="B5">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Krzanowski</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Bodzon</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Dimitrow</surname>
              <given-names>PP</given-names>
            </name>
          </person-group>
          <article-title>Imaging of all three coronary arteries by transthoracic echocardiography: an illustrated guide</article-title>
          <source>Cardiovasc Ultrasound</source>
          <year>2003</year>
          <volume>1</volume>
          <fpage>16</fpage>
          <pub-id pub-id-type="pmid">14622441</pub-id>
          <pub-id pub-id-type="doi">10.1186/1476-7120-1-16</pub-id>
        </citation>
      </ref>
      <ref id="B6">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rigo</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Coronary flow reserve in stress-echo lab. From pathophysiologic toy to diagnostic tool</article-title>
          <source>Cardiovasc Ultrasound</source>
          <year>2005</year>
          <volume>3</volume>
          <fpage>8</fpage>
          <pub-id pub-id-type="pmid">15792499</pub-id>
          <pub-id pub-id-type="doi">10.1186/1476-7120-3-8</pub-id>
        </citation>
      </ref>
      <ref id="B7">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Watanabe</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Akasaka</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Yamaura</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Akiyama</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kaji</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Saito</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Yoshida</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Intramyocardial coronary flow characteristics in patients with hypertrophic cardiomyopathy: non-invasive assessment by transthoracic Doppler echocardiography</article-title>
          <source>Heart</source>
          <year>2003</year>
          <volume>89</volume>
          <fpage>657</fpage>
          <lpage>658</lpage>
          <pub-id pub-id-type="pmid">12748226</pub-id>
          <pub-id pub-id-type="doi">10.1136/heart.89.6.657</pub-id>
        </citation>
      </ref>
      <ref id="B8">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sachdev</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Takenaka</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Teraguci</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Tei</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>McKenna</surname>
              <given-names>WJ</given-names>
            </name>
            <name>
              <surname>Elliott</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Prevalence of Anderson-Fabry disease in male patients with late onset of hypertrophic cardiomyopathy</article-title>
          <source>Circulation</source>
          <year>2002</year>
          <volume>105</volume>
          <fpage>1407</fpage>
          <lpage>1411</lpage>
          <pub-id pub-id-type="pmid">11914245</pub-id>
          <pub-id pub-id-type="doi">10.1161/01.CIR.0000012626.81324.38</pub-id>
        </citation>
      </ref>
      <ref id="B9">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chimenti</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Pieroni</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Morgante</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Antuzzi</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Russo</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Russo</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Maseri</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Frustaci</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Prevalence of Fabry disease in female patients with late-onset hypertrophic cardiomyopathy</article-title>
          <source>Circulation</source>
          <year>2004</year>
          <volume>110</volume>
          <fpage>1047</fpage>
          <lpage>1053</lpage>
          <pub-id pub-id-type="pmid">15313943</pub-id>
          <pub-id pub-id-type="doi">10.1161/01.CIR.0000139847.74101.03</pub-id>
        </citation>
      </ref>
      <ref id="B10">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Weidemann</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Breunig</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Beer</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sandstede</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Turschner</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Voelker</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Ertl</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Knoll</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Wanner</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Strotmann</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
          <article-title>Improvement of cardiac function during enzyme replacement therapy in patients with Fabry disease: a prospective strain rate imaging study</article-title>
          <source>Circulation</source>
          <year>2003</year>
          <volume>108</volume>
          <fpage>1299</fpage>
          <lpage>1301</lpage>
          <pub-id pub-id-type="pmid">12952834</pub-id>
          <pub-id pub-id-type="doi">10.1161/01.CIR.0000091253.71282.04</pub-id>
        </citation>
      </ref>
      <ref id="B11">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nagueh</surname>
              <given-names>SF</given-names>
            </name>
          </person-group>
          <article-title>Fabry disease</article-title>
          <source>Heart</source>
          <year>2003</year>
          <volume>89</volume>
          <fpage>819</fpage>
          <lpage>820</lpage>
          <pub-id pub-id-type="pmid">12860841</pub-id>
          <pub-id pub-id-type="doi">10.1136/heart.89.8.819</pub-id>
        </citation>
      </ref>
      <ref id="B12">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pieroni</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Chimenti</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Ricci</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Sale</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Russo</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Frustaci</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Early detection of Fabry cardiomyopathy by tissue Doppler imaging</article-title>
          <source>Circulation</source>
          <year>2003</year>
          <volume>107</volume>
          <fpage>1978</fpage>
          <lpage>1984</lpage>
          <pub-id pub-id-type="pmid">12668521</pub-id>
          <pub-id pub-id-type="doi">10.1161/01.CIR.0000061952.27445.A0</pub-id>
        </citation>
      </ref>
      <ref id="B13">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Moon</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Sachdev</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Elkington</surname>
              <given-names>AG</given-names>
            </name>
            <name>
              <surname>McKenna</surname>
              <given-names>WJ</given-names>
            </name>
            <name>
              <surname>Mehta</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Pennell</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Leed</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Elliott</surname>
              <given-names>PM</given-names>
            </name>
          </person-group>
          <article-title>Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium</article-title>
          <source>Eur Heart J</source>
          <year>2003</year>
          <volume>24</volume>
          <fpage>2151</fpage>
          <lpage>2155</lpage>
          <pub-id pub-id-type="pmid">14643276</pub-id>
          <pub-id pub-id-type="doi">10.1016/j.ehj.2003.09.017</pub-id>
        </citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
